We are live on ! Find out more

Natural Alternatives International

NAII

Market cap $6.06M

0.9666 USD

+0.0161

1.69%

At close Updated Nov 13, 4:00 PM EST

Pre-market

After hours

0.9251

-0.0415

4.29%

1 day

1.69%

5 days

-11.32%

1 month

-15.95%

3 months

-55.46%

6 months

-64.33%

Year to date

-73.08%

1 year

-71.23%

5 years

-93.28%

10 years

-91.88%

About: Natural Alternatives International Inc is formulator, manufacturer and marketer of nutritional supplements. Its comprehensive strategic partnerships with its customers allow to offer a wide range of nutritional products and services to such customers including scientific research, clinical studies, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management and support, packaging and delivery system design, regulatory review, and international product registration assistance. It has two segments Private-label contract manufacturing, and Patent and trademark licensing. Majority of revenue comes from Private-label contract manufacturing. Majority of revenue comes from United States.

Employees: 230

Consumer Staples Packaged Foods

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 0%

Neutral 100%

Negative 0%

Natural Alternatives International, Inc. Announces Fiscal 2027 Q1 Results

CARLSBAD, Calif., Nov. 13, 2026 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, announced today a net loss of $2.5 million, or ($0.41) per diluted share, on net sales of $28.1 million for the first quarter of fiscal year 2027 compared to a net loss of $0.3 million, or ($0.05) per diluted share, in the first quarter of the prior fiscal year.

Natural Alternatives International, Inc. Announces Fiscal 2027 Q1 Results

Zacks Investment Research

Natural Alternatives Q4 Loss Widens Y/Y on Margin Pressure

NAII posts y/y sales growth in Q4'26, but a $10.4M impairment charge and factory underutilization weigh on profitability.

Natural Alternatives Q4 Loss Widens Y/Y on Margin Pressure

Natural Alternatives International, Inc. Announces Fiscal 2026 Q4 and YTD Results

CARLSBAD, Calif., Sept. 28, 2026 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, announced today a net loss of $13.5 million, or ($2.23) per diluted share, on net sales of $34.5 million for the fourth quarter of fiscal year 2026 compared to a net loss of $7.2 million, or ($1.20) per diluted share, in the fourth quarter of the prior fiscal year. Our net loss for the fourth quarter of fiscal 2026 includes a non-recurring non-cash charge of $10.4 million related to the impairment of our Carlsbad, CA manufacturing facility due to its underutilization. Excluding this charge, our net loss for the fourth quarter of fiscal 2026 would have been $3.1 million, or ($0.52) per diluted share.

Natural Alternatives International, Inc. Announces Fiscal 2026 Q4 and YTD Results

Zacks Investment Research

3 Microcaps for Your Watchlist

NHTC, HCWC, and NAII sell into the growing nutrition and wellness space.

3 Microcaps for Your Watchlist

Top 3 Risk Off Stocks That May Rocket Higher In Q3

The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.

Top 3 Risk Off Stocks That May Rocket Higher In Q3

Zacks Investment Research

Natural Alternatives Q3 Loss Widens Y/Y on Margin Pressure

NAII's Q3 sales rise 23% y/y, but a wider loss and margin pressure offset gains from stronger contract manufacturing demand.

Natural Alternatives Q3 Loss Widens Y/Y on Margin Pressure

Natural Alternatives International, Inc. Announces 2026 Q3 and YTD Results

CARLSBAD, Calif., May 19, 2026 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $4.3 million, or $0.72 per diluted share, on net sales of $35.5 million for the third quarter of fiscal year 2026 compared to a net loss of $2.2 million, or $0.37 per diluted share, in the third quarter of the prior fiscal year.

Natural Alternatives International, Inc. Announces 2026 Q3 and YTD Results

Zacks Investment Research

Natural Alternatives Q2 Loss Widens Y/Y, Sales Increase

NAII posts higher Q2 sales but wider losses, and trims its outlook for fiscal 2026 amid softer customer forecasts and launch delays.

Natural Alternatives Q2 Loss Widens Y/Y, Sales Increase

Natural Alternatives International, Inc. Announces 2026 Q2 and YTD Results

CARLSBAD, Calif., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $2.6 million, or $0.42 per diluted share, on net sales of $34.8 million for the second quarter of fiscal year 2026 compared to a net loss of $2.2 million, or $0.37 per diluted share, in the second quarter of the prior fiscal year.

Natural Alternatives International, Inc. Announces 2026 Q2 and YTD Results

Zacks Investment Research

Niche Focus & Regulation Shape the Future of Healthcare Firms

CPIX, NAII and ICCC lean into specialization, compliance and targeted growth to thrive in the niche healthcare markets.

Niche Focus & Regulation Shape the Future of Healthcare Firms

See News Rankings

Price charts implemented using Lightweight Charts™